中山大学几个校区-中山大学几个校区
南京医科大学破格、拔尖申报高级职务科研能力测定一览表
（
2018
）
姓
名
现
职
称
叶金海
副教授
主任医师
所在学院
现职时间
口腔医学院
2011
电子邮箱
学历学位
申报职称
研究生
博士学位
教授
联
系
电
话（请提供真实手机号码）
请在附件中额外提供高校教师资格证（复印件）、境外研修证明。
一、出版物
1.
外文期刊论文
本人角色<
/p>
（通讯作者、
题
目
In situ release of VEGF enhances
osteogenesis in 3D porous
scaffolds
engineered with Osterix-modified adipose-derived
stem
cells.
The
overexpressed functional transient receptor
potential channel
TRPM2 in oral
squamous cell carcinoma.
Critical-size
calvarial bone defects healing in a mouse model
with
silk scaffolds and SATB2-modified
iPSCs.
Tissue Eng Part
A.
2017-01
通讯作者（
2
人）
刊物全称
发表时间
< br>第一作者、共同通讯作
者、共同第一作者、第
N
< br>作者）
是否
SCI
收录
SCI
影响
因子
分值
是
是
是
是
是
是
是
是
是
是
是
是
是
IF=3.892
Scientific Reports
Biomaterials
2016-12
2011-08
通讯作者（
2
人）
第一作者（<
/p>
2
人）
IF=5.228
IF=7.404
External
root
resorption
of
the
second
molar
associated
with
mesially
and
horizontally
impacted
mandibular
third
molar:
Clin Oral Investig.
evidence from cone beam computed
tomography.
SATB2-Nanog
axis
links
age-related
intrinsic
changes
of
Aging (Albany
NY).
mesenchymal stem cells from
craniofacial bone.
Alteration
of serum lipid profile and its prognostic value in
head
and neck squamous cell
carcinoma.
J Oral Pathol Med.
2017-05
第七作者
IF=2.036
2016-09
2016-03
2016-04
2016-02
2015-05
2015-10
2015-06
2014-12
第九作者
第五作者
第九作者
第八作者
第六作者
第八作者
第十作者
第七作者
IF=4.867
IF=2.036
IF=5.992
IF=5.008
IF=1.734
IF=2.884
IF=5.367
IF=4.202
The
histone
demethylase
LSD1
is
a
novel
oncogene
and
Cancer Lett.
therapeutic target in
oral cancer.
Axon
guidance
molecule
semaphorin3A
is
a
novel
tumor
suppressor in
head and neck squamous cell carcinoma.
Medial sural artery
perforator flap for postsurgical reconstruction of
head and neck cancer.
The pluripotency factor
LIN28B is involved in oral carcinogenesis
and associates with tumor
aggressiveness and unfavorable
prognosis.
The Hippo
transducer TAZ promotes epithelial to mesenchymal
transition and cancer stem cell
maintenance in oral cancer.
Oncogenic roles of Bmi1 and its
therapeutic inhibition by histone
deacetylase inhibitor in tongue
cancer.
Reconstruction of
palatomaxillary defects following cancer ablation
with temporalis muscle flap in
medically compromised patients: a
15-year single institutional
experience.
Overexpression
of metabolic markers PKM2 and LDH5 correlates
with aggressive clinicopathological
features and adverse patients'
prognosis in tongue cancer.
pH-responsive star-shaped
functionalized poly(ethylene
glycol)-b-
poly(ε
-caprolactone) with amino groups.
Transcription factor
and bone marrow stromal cells in
osseointegration of dental
implants.
The polycomb group
protein EZH2 is a novel therapeutic target in
tongue cancer.
Overexpression of Hippo pathway
effector TAZ in tongue squamous
cell
carcinoma: correlation with clinicopathological
features and
patient
prognosis.
Spontaneous
malignant transformation of craniomaxillofacial
fibrous
dysplasia.
Membrane Type 1 Matrix
Metalloproteinase induces an epithelial to
mesenchymal transition and cancer stem
cell-like properties in SCC9
cells.
Contribution of SATB2 to
the stronger osteogenic potential of bone
marrow stromal cells from craniofacial
bones.
An epidemiological
and clinical analysis of craniomaxillofacial
fibrous dysplasia in a Chinese
population.
Expression of
semaphorin 3A and neuropilin 1 with
clinicopathological features and
survival in human tongue cancer.
Cell Tissue Res.
Orphanet J Rare
Dis.
Med Oral Patol
Oral Cir Bucal.
BMC Cancer.
J
Craniofac Surg.
Colloid and
Polymer Science.
Eur Cell Mater.
Oncotarget.
Histopathology.
Clin Oral Investig.
Oncotarget.
J
Reconstr
Microsurg.
Cancer Cell Int.
Mol Oncol.
Lab Invest.
2014-07
第七作者
IF=2.352
2014-12
第六作者
是
是
是
是
是
是
是
是
是
是
IF=3.453
2014-05
2013-07
2013-12
第四作者
第四作者
第八作者
IF=1.865
IF=4.887
IF=6.627
J Oral Pathol Med.
2013-11
第七作者
IF=1.87
2013-1
第四作者
IF=0.676
2013-04
第五作者
IF=3.319
2012-12
2012-10
2012-10
第五作者
第五作者
第六作者
IF=3.677
IF=4.315
IF=1.017